


| Key | % Net Assets |
|---|---|
| 5.8% | |
| 4.9% | |
| 4.2% | |
| 3.9% | |
| 81.2% |
| Name | % Net Assets |
|---|---|
| GlaxoSmithKline PLC | 5.8% |
| BG Group PLC | 4.9% |
| AstraZeneca PLC | 4.2% |
| Royal Dutch Shell PLC | 3.9% |
| HSBC HLDGS | 3.6% |
| BRITISH AMERICAN TOBACCO | 3.6% |
| Imperial Tobacco Group PLC | 3.5% |
| British American Tobacco PLC | 3.3% |
| Wolseley PLC | 2.9% |
| Legal & General Group PLC | 2.9% |
No asset data available.
| Date | 01-Mar-2024 |
|---|---|
| NAV | 132.22p |
| Currency | GBP |
| Change | 0.76p |
| % | 0.58% |
| YTD change | 132.22p |
| YTD % | n/a |
| Fund Inception | 31/05/1976 |
|---|---|
| Fund Manager | Chris White |
| TER | 1.56 (30-Mar-2012) |
| Minimum Investment | |
|---|---|
| Initial | £500000 |
| Additional | n/a |
| Savings | n/a |
| Charges | |
|---|---|
| Initial | n/a |
| Annual Mang't | 1.50% |
| Exit | n/a |
| Name | % |
|---|---|
| Standard deviation | 0.02 |
| Sharpe ratio | 0.05 |
You are here: research